Evidence map›Paper›PMID 28159161›Full record

ReviewClinics in chest medicine2017

Atypical Pneumonia: Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia.

Lokesh Sharma, Ashley Losier, Thomas Tolbert, Charles S Dela Cruz, Chad R Marion

Abstract readReview
In one paragraph

Review in Clinics in chest medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Independent risk factors for refractory mycoplasma pneumoniae pneumonia in children: a multivariate analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  5. Doxycycline forThe Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2026
    Review
  6. Article
  7. Frontiers in cellular and infection microbiology · 2026
    Review
  8. From coughs to complications: the story ofJournal of medical microbiology · 2025
    Review
  9. Review
  10. A case-control study onFrontiers in medicine · 2025
    Article
  11. Comparison of clinical features betweenFrontiers in medicine · 2025
    Article
  12. Article
  13. Article
  14. Atypical pneumonia (Review).Experimental and therapeutic medicine · 2024
    Review
  15. Article
  16. Review
  17. Atypical bacterial respiratory infections in children.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2024
    Article
  18. Article
  19. [Macrolide-resistant Mycoplasma pneumoniae: Do we know the situation in Europe?]Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lokesh SharmaSection of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, 300 Cedar Street, TAC S440, New Haven, CT 06510, USA.
Ashley LosierDepartment of Internal Medicine, Norwalk Hospital, 34 Maple Street, Norwalk, CT 06856, USA.
Thomas TolbertDepartment of Internal Medicine, Yale University School of Medicine, 330 Cedar Street, New Haven, CT 06510, USA.
Charles S Dela CruzSection of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, 300 Cedar Street, TAC S440, New Haven, CT 06510, USA.
Chad R MarionSection of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, 300 Cedar Street, TAC S440, New Haven, CT 06510, USA. Electronic address: chad.marion@yale.edu.

Funding

Host-Pneumococcal Interaction in the LungR01HL126094 · NHLBI · YALE UNIVERSITY · PI DELA CRUZ, CHARLES S · 2015 to 2019
$2.1M
NHLBI NIH HHS R01 HL126094
6 · The paper itself

Abstract

Community-acquired pneumonia (CAP) has multiple causes and is associated with illness that requires admission to the hospital and mortality. The causes of atypical CAP include Legionella species, Chlamydophila, and Mycoplasma. Atypical CAP remains a diagnostic challenge and, therefore, likely is undertreated. This article reviews the advancements in the evaluation and treatment of patients and discusses current conflicts and controversies of atypical CAP.

Indexed as

ChlamydophilaCommunity-Acquired InfectionsHumansLegionellaPneumonia, BacterialPneumonia, MycoplasmaChlamydophilaCommunity-acquired pneumonia (CAP)LegionellaLegionnaires’ diseaseMycoplasmaPontiac feverWalking pneumonia

Identifiers

PMID28159161
PMCPMC5679202

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.